Presentation TCT 2016 Editorial Perspective: Given DCB Results, Is There Any Role for Stenting or Atherectomy in SFA Intervention? Presenter: Lawrence A. Garcia November 01, 2016 REGISTER for free or LOG IN to view this content Endovascular Presentation TCT 2016 Femoral Up Next Presentation TCT 2016 Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See Presenter: Katherine Wallon November 01, 2016 More slides + Presentation TCT 2016 DCB in BTK Intervention: Necessary Technical and Clinical Improvements to Unlock" the BTK Application Presenter: Mahmood K. Razavi November 01, 2016 Presentation TCT 2016 Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives Presenter: Brian K. Whisenant November 01, 2016 We Recommend
Presentation TCT 2016 Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See Presenter: Katherine Wallon November 01, 2016
Presentation TCT 2016 DCB in BTK Intervention: Necessary Technical and Clinical Improvements to Unlock" the BTK Application Presenter: Mahmood K. Razavi November 01, 2016
Presentation TCT 2016 Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives Presenter: Brian K. Whisenant November 01, 2016